Variant report
Variant | esv1802545 |
---|---|
Chromosome Location | chr2:55668771-55687618 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:82)
- CpG islands (count:122)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr2:55687010-55687270 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr2:55686492-55686745 | K562 | blood: | n/a | n/a |
3 | ATF1 | chr2:55668598-55669016 | K562 | blood: | n/a | n/a |
4 | ATF3 | chr2:55668631-55668999 | K562 | blood: | n/a | n/a |
5 | BHLHE40 | chr2:55687159-55687554 | K562 | blood: | n/a | n/a |
6 | CBX3 | chr2:55686408-55687583 | K562 | blood: | n/a | n/a |
7 | CEBPD | chr2:55668581-55668997 | K562 | blood: | n/a | n/a |
8 | CREB1 | chr2:55668553-55669043 | K562 | blood: | n/a | n/a |
9 | CTCF | chr2:55682918-55683033 | GM20000 | blood: | n/a | n/a |
10 | CTCF | chr2:55670492-55670537 | GM10266 | blood: | n/a | n/a |
11 | EGR1 | chr2:55686942-55687351 | K562 | blood: | n/a | n/a |
12 | EGR1 | chr2:55686905-55687222 | K562 | blood: | n/a | n/a |
13 | EP300 | chr2:55684518-55684536 | K562 | blood: | n/a | n/a |
14 | EP300 | chr2:55668607-55669033 | K562 | blood: | n/a | n/a |
15 | EP300 | chr2:55687422-55687793 | K562 | blood: | n/a | chr2:55687747-55687761 |
16 | EP300 | chr2:55686530-55687190 | K562 | blood: | n/a | chr2:55686532-55686542 |
17 | FOXA1 | chr2:55669513-55669804 | HepG2 | liver: | n/a | n/a |
18 | FOXA1 | chr2:55669524-55669971 | HepG2 | liver: | n/a | n/a |
19 | FOXA2 | chr2:55669548-55669911 | A549 | lung: | n/a | n/a |
20 | FOXA2 | chr2:55669313-55670071 | A549 | lung: | n/a | n/a |
21 | GATA1 | chr2:55668290-55669044 | K562 | blood: | n/a | chr2:55668531-55668541 chr2:55668533-55668540 chr2:55668533-55668540 chr2:55668533-55668540 |
22 | HCFC1 | chr2:55687236-55687393 | K562 | blood: | n/a | n/a |
23 | IRF1 | chr2:55687050-55688084 | K562 | blood: | n/a | chr2:55687905-55687926 chr2:55687909-55687920 chr2:55687907-55687921 chr2:55687911-55687921 chr2:55687911-55687925 chr2:55687909-55687929 chr2:55687910-55687924 |
24 | JUN | chr2:55668668-55668983 | K562 | blood: | n/a | chr2:55668817-55668830 |
25 | JUN | chr2:55668615-55668990 | K562 | blood: | n/a | chr2:55668817-55668830 |
26 | JUN | chr2:55668703-55668921 | HepG2 | liver: | n/a | chr2:55668817-55668830 |
27 | JUN | chr2:55686877-55687214 | K562 | blood: | n/a | n/a |
28 | JUN | chr2:55668657-55668953 | K562 | blood: | n/a | chr2:55668817-55668830 |
29 | JUND | chr2:55686480-55686642 | K562 | blood: | n/a | n/a |
30 | JUND | chr2:55668682-55668964 | HepG2 | liver: | n/a | n/a |
31 | JUND | chr2:55686865-55687374 | K562 | blood: | n/a | n/a |
32 | JUND | chr2:55668442-55669013 | K562 | blood: | n/a | n/a |
33 | MAFK | chr2:55686934-55687217 | K562 | blood: | n/a | n/a |
34 | MAX | chr2:55669226-55669612 | MCF-7 | breast: | n/a | n/a |
35 | MAX | chr2:55668651-55668917 | K562 | blood: | n/a | n/a |
36 | MAZ | chr2:55686488-55687289 | K562 | blood: | n/a | n/a |
37 | MYC | chr2:55668610-55668972 | K562 | blood: | n/a | n/a |
38 | MYC | chr2:55669375-55669414 | MCF-7 | breast: | n/a | n/a |
39 | MYC | chr2:55668633-55668923 | K562 | blood: | n/a | n/a |
40 | NR2F2 | chr2:55686868-55687327 | K562 | blood: | n/a | n/a |
41 | NR2F2 | chr2:55686795-55687577 | K562 | blood: | n/a | n/a |
42 | PAX5 | chr2:55680107-55680553 | GM12892 | blood: | n/a | chr2:55680274-55680283 chr2:55680274-55680292 chr2:55680273-55680290 chr2:55680273-55680292 |
43 | PAX5 | chr2:55680143-55680392 | GM12878 | blood: | n/a | chr2:55680274-55680283 chr2:55680274-55680292 chr2:55680273-55680290 chr2:55680273-55680292 |
44 | PAX5 | chr2:55680009-55680561 | GM12878 | blood: | n/a | chr2:55680274-55680283 chr2:55680274-55680292 chr2:55680273-55680290 chr2:55680273-55680292 |
45 | PAX5 | chr2:55680080-55680465 | GM12878 | blood: | n/a | chr2:55680274-55680283 chr2:55680274-55680292 chr2:55680273-55680290 chr2:55680273-55680292 |
46 | PAX5 | chr2:55680086-55680503 | GM12878 | blood: | n/a | chr2:55680274-55680283 chr2:55680274-55680292 chr2:55680273-55680290 chr2:55680273-55680292 |
47 | PAX5 | chr2:55680141-55680436 | GM12892 | blood: | n/a | chr2:55680274-55680283 chr2:55680274-55680292 chr2:55680273-55680290 chr2:55680273-55680292 |
48 | PAX5 | chr2:55680019-55680509 | GM12891 | blood: | n/a | chr2:55680274-55680283 chr2:55680274-55680292 chr2:55680273-55680290 chr2:55680273-55680292 |
49 | POLR2A | chr2:55669306-55669445 | A549 | lung: | n/a | n/a |
50 | POLR2A | chr2:55669322-55669430 | A549 | lung: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:55669512-55669562 | HRCEpiC | kidney: | n/a |
2 | chr2:55669512-55669562 | Jurkat | blood: | n/a |
3 | chr2:55669528-55669578 | HRPEpiC | eye: | n/a |
4 | chr2:55669512-55669562 | GM12878 | blood: | n/a |
5 | chr2:55669528-55669578 | Jurkat | blood: | n/a |
6 | chr2:55669512-55669562 | Hepatocyte | liver: | n/a |
7 | chr2:55669528-55669578 | SKMC | muscle: | n/a |
8 | chr2:55669512-55669562 | HCF | heart: | n/a |
9 | chr2:55669512-55669562 | SK-N-MC | brain: | n/a |
10 | chr2:55669512-55669562 | HRPEpiC | eye: | n/a |
11 | chr2:55669512-55669562 | AG10803 | skin: | n/a |
12 | chr2:55669512-55669562 | AG04449 | skin: | fetal |
13 | chr2:55669528-55669578 | AG10803 | skin: | n/a |
14 | chr2:55669528-55669578 | Hepatocyte | liver: | n/a |
15 | chr2:55669512-55669562 | BJ | skin: | n/a |
16 | chr2:55669512-55669562 | SK-N-SH | brain: | n/a |
17 | chr2:55669512-55669562 | HUVEC | blood vessel: | n/a |
18 | chr2:55669512-55669562 | MCF10A-Er-Src | breast: | n/a |
19 | chr2:55669528-55669578 | AG09319 | gingival: | n/a |
20 | chr2:55669528-55669578 | GM19239 | blood: | n/a |
21 | chr2:55669528-55669578 | HMEC | breast: | n/a |
22 | chr2:55669512-55669562 | AG04450 | lung: | fetal |
23 | chr2:55669512-55669562 | HepG2 | liver: | n/a |
24 | chr2:55669528-55669578 | NB4 | blood: | n/a |
25 | chr2:55669528-55669578 | BE2_C | brain: | n/a |
26 | chr2:55669528-55669578 | LNCaP | prostate: | n/a |
27 | chr2:55669512-55669562 | ProgFib | skin: | n/a |
28 | chr2:55669512-55669562 | HMEC | breast: | n/a |
29 | chr2:55669512-55669562 | NT2-D1 | testis: | n/a |
30 | chr2:55669512-55669562 | HL-60 | blood: | n/a |
31 | chr2:55669528-55669578 | GM12878 | blood: | n/a |
32 | chr2:55669512-55669562 | HCM | heart: | n/a |
33 | chr2:55669512-55669562 | U87 | brain: | n/a |
34 | chr2:55669528-55669578 | IMR90 | lung: | fetal |
35 | chr2:55669512-55669562 | A549 | lung: | n/a |
36 | chr2:55669512-55669562 | GM12892 | blood: | n/a |
37 | chr2:55669512-55669562 | GM19239 | blood: | n/a |
38 | chr2:55669512-55669562 | NHDF-neo | bronchial: | n/a |
39 | chr2:55669528-55669578 | GM12891 | blood: | n/a |
40 | chr2:55669512-55669562 | GM06990 | blood: | n/a |
41 | chr2:55669512-55669562 | MCF-7 | breast: | n/a |
42 | chr2:55669528-55669578 | K562 | blood: | n/a |
43 | chr2:55669528-55669578 | A549 | lung: | n/a |
44 | chr2:55669528-55669578 | HCF | heart: | n/a |
45 | chr2:55669528-55669578 | HL-60 | blood: | n/a |
46 | chr2:55669528-55669578 | ECC-1 | luminal epithelium: | n/a |
47 | chr2:55669512-55669562 | K562 | blood: | n/a |
48 | chr2:55669528-55669578 | HUVEC | blood vessel: | n/a |
49 | chr2:55669512-55669562 | BE2_C | brain: | n/a |
50 | chr2:55669528-55669578 | NT2-D1 | testis: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:55687006..55688643-chr2:55695301..55697827,2 | K562 | blood: | |
2 | chr2:55685859..55688576-chr2:55704168..55705704,2 | K562 | blood: | |
3 | chr2:55685859..55689699-chr2:55700621..55705668,4 | K562 | blood: | |
4 | chr2:55676747..55678415-chr2:55678423..55681362,2 | K562 | blood: | |
5 | chr2:55461063..55464036-chr2:55678930..55681673,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-221P | TF binding region |
RNU6-775P | TF binding region |
RNU6-221P | CpG island |
RNU6-775P | CpG island |
ENSG00000238619 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13028756 | chr2:55668771-55668772 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs74514652 | chr2:55668775-55668776 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184463309 | chr2:55668779-55668780 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529010571 | chr2:55668794-55668795 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs146124104 | chr2:55668795-55668796 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563814837 | chr2:55668807-55668808 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6745759 | chr2:55668829-55668830 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs139924112 | chr2:55668832-55668833 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531659766 | chr2:55668847-55668848 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs55652944 | chr2:55668861-55668862 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534875849 | chr2:55668876-55668877 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200808595 | chr2:55668950-55668951 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs56409619 | chr2:55669004-55669005 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs112878836 | chr2:55669010-55669011 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184784105 | chr2:55669020-55669021 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577034206 | chr2:55669035-55669036 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539567844 | chr2:55669036-55669037 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs373825428 | chr2:55669045-55669046 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7423127 | chr2:55669084-55669085 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553087598 | chr2:55669085-55669086 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs372950088 | chr2:55669102-55669103 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375654317 | chr2:55669104-55669105 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537860328 | chr2:55669105-55669106 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533776403 | chr2:55669121-55669122 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189693950 | chr2:55669141-55669142 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143966406 | chr2:55669145-55669146 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181039703 | chr2:55669156-55669157 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543816799 | chr2:55669208-55669209 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560461631 | chr2:55669215-55669216 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563507324 | chr2:55669261-55669262 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532353374 | chr2:55669278-55669279 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552290175 | chr2:55669284-55669285 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559414700 | chr2:55669294-55669295 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528662455 | chr2:55669319-55669320 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6749238 | chr2:55669326-55669327 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs185224316 | chr2:55669338-55669339 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537316436 | chr2:55669344-55669345 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189595054 | chr2:55669350-55669351 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114686010 | chr2:55669365-55669366 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539430900 | chr2:55669372-55669373 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs79572372 | chr2:55669378-55669379 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553150769 | chr2:55669379-55669380 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113409076 | chr2:55669383-55669384 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572929335 | chr2:55669395-55669396 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535649361 | chr2:55669398-55669399 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs72801524 | chr2:55669403-55669404 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs575517954 | chr2:55669407-55669408 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544209524 | chr2:55669408-55669409 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557616676 | chr2:55669409-55669410 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs78715583 | chr2:55669418-55669419 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ependymoma | 20639864 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:55668400-55669400 | Enhancers | K562 | blood |
2 | chr2:55668600-55669000 | Flanking Active TSS | A549 | lung |
3 | chr2:55669000-55669600 | Active TSS | A549 | lung |
4 | chr2:55678600-55679200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr2:55678800-55679200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr2:55678800-55679200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
7 | chr2:55678800-55679200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr2:55678800-55679200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr2:55678800-55679200 | Enhancers | NHEK | skin |
10 | chr2:55679200-55681400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr2:55680000-55680400 | Enhancers | Fetal Kidney | kidney |
12 | chr2:55680000-55680600 | Enhancers | GM12878-XiMat | blood |
13 | chr2:55681400-55681600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr2:55681400-55683400 | Enhancers | Fetal Heart | heart |
15 | chr2:55684400-55685000 | Enhancers | K562 | blood |
16 | chr2:55685000-55686200 | Weak transcription | K562 | blood |
17 | chr2:55686200-55686600 | Enhancers | K562 | blood |
18 | chr2:55686600-55688200 | Flanking Active TSS | K562 | blood |
19 | chr2:55687200-55687800 | Active TSS | Osteobl | bone |
20 | chr2:55687600-55688000 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr2:55687600-55688200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
22 | chr2:55687600-55688600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |